- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 49.55M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 50.2M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 51.25M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $124.2M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $64.3M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $44M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $40.9M |
| Capex | Q1 2026 · Mar 31, 2026 | $47.7M |
| Capex | Q1 2026 · Mar 31, 2025 | $53.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $240.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $392.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.59B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.83B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $5.87B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.87B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $5.23B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $5.11B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $29.9B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $30.42B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $35.77B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $36.29B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $5.41 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $2.83 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $5.47 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $2.86 |
| Net Income | Q1 2026 · Mar 31, 2026 | $274.1M |
| Net Income | Q1 2026 · Mar 31, 2025 | $146.6M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.42B |
| Revenue | Q1 2026 · Mar 31, 2025 | $3.07B |